HRP20090411T1 - Suspenzijska formulacija feksofenadina - Google Patents

Suspenzijska formulacija feksofenadina Download PDF

Info

Publication number
HRP20090411T1
HRP20090411T1 HR20090411T HRP20090411T HRP20090411T1 HR P20090411 T1 HRP20090411 T1 HR P20090411T1 HR 20090411 T HR20090411 T HR 20090411T HR P20090411 T HRP20090411 T HR P20090411T HR P20090411 T1 HRP20090411 T1 HR P20090411T1
Authority
HR
Croatia
Prior art keywords
approximately
aqueous pharmaceutical
suspension according
pharmaceutical suspension
volume
Prior art date
Application number
HR20090411T
Other languages
English (en)
Croatian (hr)
Inventor
Agrawala Prafulla
Chrzan Kazimierz
Haribhakti Rajiv
Mermey Matthew
J. Porcello Curtis
Lee Silvey Gary
Tran Vinh
Original Assignee
Sanofi-Aventis U.S. Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38120312&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20090411(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi-Aventis U.S. Llc filed Critical Sanofi-Aventis U.S. Llc
Publication of HRP20090411T1 publication Critical patent/HRP20090411T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
HR20090411T 2005-12-14 2006-12-12 Suspenzijska formulacija feksofenadina HRP20090411T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75030305P 2005-12-14 2005-12-14
PCT/US2006/047393 WO2007070517A2 (fr) 2005-12-14 2006-12-12 Suspension de fexofenadine

Publications (1)

Publication Number Publication Date
HRP20090411T1 true HRP20090411T1 (hr) 2010-01-31

Family

ID=38120312

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090411T HRP20090411T1 (hr) 2005-12-14 2006-12-12 Suspenzijska formulacija feksofenadina

Country Status (38)

Country Link
US (1) US8933097B2 (fr)
EP (1) EP1965768B1 (fr)
JP (1) JP5308824B2 (fr)
KR (1) KR101452792B1 (fr)
CN (1) CN101316580B (fr)
AR (1) AR058323A1 (fr)
AT (1) ATE431137T1 (fr)
AU (1) AU2006326551B2 (fr)
BR (1) BRPI0619895B1 (fr)
CA (1) CA2633086C (fr)
CR (1) CR9993A (fr)
CY (1) CY1109320T1 (fr)
DE (1) DE602006006870D1 (fr)
DK (1) DK1965768T3 (fr)
DO (1) DOP2006000274A (fr)
EC (1) ECSP088532A (fr)
EG (1) EG25866A (fr)
ES (1) ES2327168T3 (fr)
HN (1) HN2008000875A (fr)
HR (1) HRP20090411T1 (fr)
IL (1) IL192067A (fr)
JO (1) JO2549B1 (fr)
MA (1) MA30152B1 (fr)
MY (1) MY146988A (fr)
NO (1) NO339877B1 (fr)
NZ (1) NZ568943A (fr)
PE (1) PE20071003A1 (fr)
PL (1) PL1965768T3 (fr)
PT (1) PT1965768E (fr)
RS (1) RS51135B (fr)
RU (1) RU2405538C2 (fr)
SI (1) SI1965768T1 (fr)
TN (1) TNSN08186A1 (fr)
TW (1) TWI377061B (fr)
UA (1) UA89584C2 (fr)
UY (1) UY30021A1 (fr)
WO (1) WO2007070517A2 (fr)
ZA (1) ZA200803985B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101546774B1 (ko) 2008-07-29 2015-08-24 엘지전자 주식회사 휴대 단말기 및 그 동작제어 방법
CA2852447A1 (fr) 2011-10-19 2013-04-25 R.P. Scherer Technologies, Llc Systeme d'administration pharmaceutique a deux phases
US10130620B2 (en) 2013-07-01 2018-11-20 Aventisub Llc Liquid pharmaceutical composition for oral administration comprising fexofenadine
BR112015032791A2 (pt) * 2013-07-03 2017-07-25 Scherer Technologies Llc R P composição para uso como enchimento de cápsula, e, cápsula
CN103610645B (zh) * 2013-11-25 2016-05-11 浙江万晟药业有限公司 一种非索非那定盐酸盐的药物组合物及制备方法
CN106806346B (zh) * 2015-12-01 2020-09-11 国药集团广东环球制药有限公司 一种非索非那定盐酸盐干混悬剂制剂及其制备方法
ES3014923T3 (en) 2016-06-16 2025-04-28 Azurity Pharmaceuticals Inc Composition and method for proton pump inhibitor suspension
EP3639812A4 (fr) 2017-06-02 2021-03-17 Teika Pharmaceutical Co., Ltd. Micelle solubilisée comprenant un composant peu soluble et solution la contenant
US11633478B2 (en) 2019-07-16 2023-04-25 Azurity Pharmaceuticals, Inc. Compositions and kits for Omeprazole suspension
US10751333B1 (en) 2019-07-16 2020-08-25 Cutispharma, Inc. Compositions and kits for omeprazole suspension
EP4199980A1 (fr) * 2020-08-18 2023-06-28 Innate S.r.l. Composition injectable et utilisation de ladite composition
WO2022175829A1 (fr) 2021-02-17 2022-08-25 Cellix Bio Private Limited Formulations et compositions topiques
AU2021480621A1 (en) * 2021-12-29 2024-07-18 Opella Healthcare Group Sas Compositions containing fexofenadine
CN115715759B (zh) * 2022-11-03 2024-01-12 京海盛达(北京)科技有限公司 一种抗组胺混悬剂及其制备方法
EP4651852A1 (fr) 2023-01-20 2025-11-26 Opella Healthcare Group SAS Formulations de fexofénadine sans parabène
WO2026074306A1 (fr) 2024-10-03 2026-04-09 Opella Healthcare Group Sas Comprimés de fexofénadine à mâcher

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4829064A (en) 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
CN1148849A (zh) * 1994-05-18 1997-04-30 赫彻斯特马里恩鲁斯公司 抗组胺哌啶衍生物，其多晶形物和假同晶物的无水和水合物形式的制备方法
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
US6319513B1 (en) * 1998-08-24 2001-11-20 The Procter & Gamble Company Oral liquid mucoadhesive compounds
GB9822170D0 (en) 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
US20060083691A1 (en) * 2000-05-10 2006-04-20 Wermeling Daniel P Intranasal opioid compositions, delivery devices and methods of using same
WO2003011295A1 (fr) 2001-07-31 2003-02-13 Texcontor Etablissement Agent polymorphe de fexofenadine
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
CA2514570C (fr) * 2003-01-30 2011-09-06 Ethypharm Particules presentant un enrobage de masquage du gout, procede de preparation associe et comprimes orodispersibles contenant lesdites particules enrobees
US20050250737A1 (en) * 2003-11-12 2005-11-10 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
US20050266031A1 (en) 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
DK2377557T3 (en) * 2004-11-24 2017-02-06 Meda Pharmaceuticals Inc Compositions comprising azelastine and methods for its use
CN101228128A (zh) 2005-07-27 2008-07-23 桑多斯股份公司 一种用于制备取代苯基醚化合物和罗西格列酮的方法
JP5133244B2 (ja) * 2005-08-05 2013-01-30 ルピン・リミテッド フェキソフェナジンの経口用医薬懸濁組成物

Also Published As

Publication number Publication date
PT1965768E (pt) 2009-08-07
PE20071003A1 (es) 2007-10-03
DK1965768T3 (da) 2009-09-07
WO2007070517A2 (fr) 2007-06-21
UY30021A1 (es) 2007-07-31
DOP2006000274A (es) 2007-10-15
JP5308824B2 (ja) 2013-10-09
JP2009519935A (ja) 2009-05-21
HN2008000875A (es) 2012-01-30
UA89584C2 (en) 2010-02-10
TW200812581A (en) 2008-03-16
IL192067A0 (en) 2009-02-11
DE602006006870D1 (de) 2009-06-25
NZ568943A (en) 2010-04-30
KR101452792B1 (ko) 2014-10-22
US20080299211A1 (en) 2008-12-04
CA2633086A1 (fr) 2007-06-21
ES2327168T3 (es) 2009-10-26
ATE431137T1 (de) 2009-05-15
MY146988A (en) 2012-10-15
RU2405538C2 (ru) 2010-12-10
BRPI0619895B1 (pt) 2022-04-12
SI1965768T1 (sl) 2009-10-31
WO2007070517A3 (fr) 2007-08-23
TNSN08186A1 (en) 2009-10-30
CA2633086C (fr) 2011-10-18
CN101316580B (zh) 2011-11-16
ZA200803985B (en) 2009-03-25
CN101316580A (zh) 2008-12-03
RS51135B (sr) 2010-10-31
TWI377061B (en) 2012-11-21
ECSP088532A (es) 2008-08-29
IL192067A (en) 2010-12-30
CY1109320T1 (el) 2014-07-02
JO2549B1 (en) 2010-09-05
AU2006326551B2 (en) 2012-06-07
CR9993A (es) 2008-09-23
EP1965768A2 (fr) 2008-09-10
KR20080074180A (ko) 2008-08-12
US8933097B2 (en) 2015-01-13
RU2008128418A (ru) 2010-01-20
BRPI0619895A2 (pt) 2011-10-25
NO20082904L (no) 2008-09-10
AR058323A1 (es) 2008-01-30
HK1123197A1 (en) 2009-06-12
MA30152B1 (fr) 2009-01-02
PL1965768T3 (pl) 2009-11-30
EG25866A (en) 2012-09-12
AU2006326551A1 (en) 2007-06-21
EP1965768B1 (fr) 2009-05-13
NO339877B1 (no) 2017-02-13

Similar Documents

Publication Publication Date Title
HRP20090411T1 (hr) Suspenzijska formulacija feksofenadina
ES2262122T3 (es) Formulacion intranasal de rotigotina.
CN103052384B (zh) 包含溴己新的含水组合物
CA2668733C (fr) Preparation liquide comprenant un complexe de pimobendane et de cyclodextrine
HK1205933A1 (en) Enhanced stability phenylephrine liquid compositions
ES2277635T3 (es) Formulacion de disolucion solida oral de una sustancia activa escasamente soluble en agua.
JP2009519935A5 (fr)
WO2016159897A1 (fr) Suspension de citrate de potassium
CN102078285A (zh) 含有皮质激素和h1受体拮抗剂的鼻用原位凝胶
MXPA97002456A (en) Liquid antiacidal compositions containing calcium carbonate and possibly simeticone as active compounds and monobasic potassium phosphate and potassium bicarbonate as regula
JPS63215622A (ja) 経口投与用医薬組成物
WO2008015695A2 (fr) Complexe d'inclusion
DK175752B1 (da) Flydende oralt farmaceutisk diclofenacpræparat og fremgangsmåde til fremstilling deraf
ES2781755T3 (es) Composición farmacéutica en forma de suspensión oral que comprende una fracción flavonoica y goma de xantano
HUE026162T2 (en) Olopatadine preparation for topical nasal administration
TWI327913B (en) Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid
US20150140111A1 (en) Preparations of effervescent formulations comprising second and third generation cephalosporin and uses thereof
CN102078612A (zh) 含有糠酸莫米松和h1受体拮抗剂的鼻用原位凝胶
ES2705238T3 (es) Composición de compuestos de tiacumicina
EP2515858A1 (fr) Composition pharmaceutique très pure
US5698562A (en) Palatable trimethoprim oral solution
KR100718211B1 (ko) 틱소코르톨 피발레이트 현탁액, 그를 기재로 한 함수제 및그를 함유하는 패키징
JPH10139666A (ja) 液剤およびその製造方法
WO2014191414A1 (fr) Formulation de sirop de salbutamol
JPH08333268A (ja) カンゾウの抽出物を配合した安定な液剤